key: cord-0862439-tx96yr4n
authors: Abbasher Hussien Mohamed Ahmed, Khabab; Hasabo, Elfatih A.; Haroun, Mazin S.; Mah. Fadelallah Eljack, Moh.; Salih, Esraa Hassan; Altayeb, Yousif F. O.; Nour, Alshareef B.; Abdallah, Abdallah M.; Osman, Waddah A. M.; Yousif, Mohammed Y. E.
title: Clinical characteristics, complications, and predictors of outcome of hospitalized adult Sudanese patients with COVID‐19 and malaria coinfection in Sudan: A multicenter retrospective cross‐sectional study
date: 2022-04-21
journal: J Med Virol
DOI: 10.1002/jmv.27771
sha: dabc4396b3dc9d05d57fef2aaddb20e5dfc11319
doc_id: 862439
cord_uid: tx96yr4n

Malaria and coronavirus disease 2019 (COVID‐19) share several characteristics that could lead to cross‐infection, particularly in malaria‐endemic areas. Early COVID‐19 symptoms might be misdiagnosed for malaria in clinical settings. Also, both diseases can cause fatal complications. So, laboratory testing for both diseases was recommended by the World Health Organization. To study the clinical characteristics and outcomes of Adult Sudanese patients with COVID‐19 and malaria coinfection. This retrospective cross‐sectional study was conducted from January 2021 to October 2021 in Wad Medani. Total coverage of all Sudanese patients above 18 years old with a confirmed diagnosis of coinfection with COVID‐19 and malaria was included, and data were collected using a data collection sheet. Data were analyzed using R software version 4.0.2. Data were described and presented as mean, standard deviation, and number (percentage). To find associated factors with in‐hospital outcome, χ (2) test, fisher exact test, and independent t test or Wilcoxon rank‐sum test were used. In this study, 156 participants were diagnosed with COVID‐19 and malaria coinfection. Most of them were between 60 and 70 years (30.8%), the majority were males (59%). Shortness of breath (76.3%) and acute respiratory distress syndrome (35.3%) were the most common symptom and complications among coinfected patients, respectively. Ground glass opacity (n = 47/49, 95.9%) is the most common result for computed tomography scan. Atrial fibrillation was the most common abnormal electrocardiogram finding (n = 6/62, 9.7%). Overall mortality among all participants was (63/156, 40.4%). High mortality rate was found among the coinfected patients. More attention is needed towards fighting COVID‐19 and malaria coinfection. There may be a link between malaria and COVID‐19.

Malaria is a mosquito-borne infectious disease caused by a plasmodium-like eukaryotic protest. 1 Malaria is one of Africa's most frequent endemic diseases, affecting 250 million people and killing one to three million people, usually children, in Sub-Saharan Africa. 2 Plasmodium falciparum and P. vivax, two morphologically identical sympatric species of P. ovale (as suggested by recent data), P. malariae, and the monkey malaria parasite P. knowlesi are the five species known to cause malaria in humans. P. falciparum produces more deadly infections, and patients can quickly develop complications such as severe anemia, acute renal injury, cerebral malaria, spontaneous bleeding and coagulopathy, and others. Its incubation period is about 10-15 days. 3 In 2020 there were about 241 million cases worldwide, Africa accounts for 95% of all cases. Southeast Asia is ranked second, followed by the eastern Mediterranean region, which is ranked third. 4 It is one of Sudan's endemic diseases and a severe public health issue. So up to date, almost 1.8 million malaria cases have been documented across Sudan. 4 Fever, headache, generalized fatigability, nausea, and vomiting are typical clinical manifestations of malaria. The severity of an infection is determined by a number of factors, including the Plasmodium species, the patient's immunity, and the infected person's overall health and nutritional status. 5, 6 Malaria laboratory diagnosis by microscopic thin and thick film, which is the gold standard for malaria identification, as well as fast antigen testing (e.g., immunochromatography [ICT] ) and nucleic acid amplification procedures, may aid in the detection of acute conditions. 7 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, a single-stranded RNA virus belonging to the Coronaviruses family, causes coronavirus disease 2019 . The outbreak began in December 2019 8 in Wuhan, China, and was declared a pandemic in March 2020 because of its rapid expansion. 9 More than 250 million instances of COVID-19 have been verified to date, with total mortality estimated over 5 million cases. As of the December 15, 2021, there are 45 112 instances in Sudan, with 3252 deaths. 10 When encountered, the major method of transmission is through respiratory droplets from person to person, 11 with an incubation period of about 5 days. 12 COVID-19's most common clinical symptoms are fever and cough. Fatigue, myalgia, headaches, and diarrhea are some of the other common symptoms. The most prevalent laboratory finding is high C-reactive protein, followed by lymphopenia and leukopenia. 13 The real-time polymerase chain reaction (RT-PCR) is a standard approach for diagnosing COVID-19, although its sensitivity is only about 71%, compared with 98% for CT chest. 14 Bilateral, peripheral, lower-lobe ground-glass opacities, and/ or consolidation are typical findings of COVID patients on CT scans. 15 Fever (70%-90%), dry cough (60%-86%), shortness of breath (53%-80%), fatigue (38%), myalgias (15%-44 %), nausea/ vomiting or diarrhea (15%-39%), headache, weakness (25%), and rhinorrhea (7%) are among the most common symptoms in admitted patients. 16 Pneumonia and acute respiratory distress syndrome are two of COVID-19's most common consequences (ARDS).

Additionally, COVID has been linked to acute liver, heart, and renal injury. 17 Age, comorbidities, immunological response, radiographic findings, laboratory data, and signs of organ dysfunction are all characteristics that might help predict the severity of the disease. 18 Malaria and COVID-19 share several characteristics that could lead to cross-infection, particularly in malaria-endemic areas. Early COVID-19 symptoms, such as fever, myalgia, and exhaustion, might be mistaken for malaria in clinical settings. Adult respiratory distress syndrome (ARDS) is a complication of both of them. 19, 20 In the meanwhile, many investigations have found that malaria and COVID-19 coinfection can be diagnosed by positive lab findings for both infections. 21 Aside from what has already been stated. Malaria and COVID-19 pose a serious threat to Sudan's already-fragmented health system. In addition, the mutual side effects of each of them add to the difficulty of determining the optimal care regimens for such deadly conditions.

There was a scarcity in the literature regarding this topic, so we aimed at throwing a stone in a pond of water. In this study our aim was to assess the presenting symptoms of malaria and COVID-19 coinfection, to find complications of malaria and COVID-19 coinfection, to describe laboratory, X-ray, computed tomography (CT), and electrocardiogram (ECG) findings, and to assess the predictors of outcomes of malaria and COVID-19 coinfection.

This was a retrospective cross-sectional study that was conducted from January 2021 to October 2021 in Wad Medani (the capital of Gezira state) which is the second largest state in Sudan, with a total population of 4 133 048. This city, composed of 32 secondary and tertiary hospitals, receives patients from Gezira, Sinnar, Blue Nile, Kassala, Gadarif, and White Nile states. Two isolation centers were involved in the study. The first (Soqatra isolation center) is composed of 65 beds for mild to moderate cases divided into a general ward (45 beds) and a high dependency unit (HDU) containing 20 beds, 24-h laboratory, pharmacy, and two ambulances. The second (Mycetoma center) for critical cases with a capacity of 10 inensive care unit (ICU) beds supplemented with 10 mechanical ventilators and two hemodialysis machines in addition to a laboratory, pharmacy, and two ambulances. The two centers are referral centers that receive patients from all middle, eastern, and southern Sudan states (six states).

We included all Sudanese patients above 18 years old with a confirmed diagnosis of co-infection with COVID-19 by RT-PCR and malaria by microscopy. All patients less than 18 years old or who tested negative for COVID-19 were excluded.

A total coverage for all consecutive patients was done in this study during the period of data collection.

Data were collected by a well-trained general practitioner using a data collection sheet containing the following items:

1. Demographic data and risk factors.

2. Vital signs (diastolic blood pressure, systolic blood pressure, respiratory rate, pulse,, and oxygen saturation).

4. Complication of COVID-19 and malaria. 5 . Laboratory investigations (WBC, hemoglobin, platelets, lymphocyte, C-reactive protein, creatinine, blood urea nitrogen, D-dimer, and random blood glucose). 6 . Chest X-ray, CT, and ECG findings. 7. Length of stay.

8. In-hospital outcome (death or discharge).

Data were analyzed using R software version 4.0.2. Data were described and presented as mean ± standard deviation (SD) and number (%age). To find associated factors with in-hospital outcome, χ 2 test, Fisher exact test, and independent t test or

Wilcoxon rank-sum test were used. 

In this study, 156 participants diagnosed with COVID-19 and malaria co-infection with mean ± SD of 65.2 ± 14.5 participated in this study.

Most of them were between 60 and 70 years (30.8%) followed by 71-80 years (23.7%). Nearly half of the participants were males (59%). Hypertension (37.2%) and diabetes (38.5%) were the most common risk factors. The mean respiratory rate was 29.8 ± 9.8 breaths per minute. All species of malaria were P. falciparum except one participant with P. vivax (Table 1 ).

Shortness of breath (76.3%), and fever (73.1%) were the most common symptoms among coinfected participants.

Regarding complications, acute respiratory distress syndrome (35.3%), thrombocytopenia (16.0%), and acute kidney injury (8.3%) were reported as the most common complications of COVID-19 and malaria coinfection ( Table 2 ).

Overall mean of total white blood cells and C-reactive protein were 11.5 ± 8.5 and 233.3 ± 746.0, respectively. Other laboratory investigations were shown in Table 3 .

Nearly more than two-third of urine samples (82.7%) were normal. The mean concentration of blood urea nitrogen was 61.6 ± 43.8 (Tables 3 and 4 ).

Bilateral consolidation was found in more than half of the participants who requested chest X-ray (n = 9/16, 56.2%). But for CT findings, most participants were having ground-glass opacity (n = 47/49, 95.9%). ECG findings were found normal in more than half of the participants (n = 33/62, 53.2%) and atrial fibrillation was the most common abnormal ECG finding (n = 6/62, 9.7%) ( Table 4 ).

Overall mortality among all participants was (63/156, 40.4%).

Shorter length of stay (p = 0.003), usage of respiratory support (p < 0.001), presence of acute respiratory distress syndrome (p < 0.001), presence of black water fever (p = 0.031), and low platelets count (p = 0.035) were found significantly associated with death in hospital (Tables 1-4) .

During using nonparametric tests, increased respiratory rate (p = 0.037) and high serum creatinine (p = 0.035) were found significantly associated with death in the hospital (Tables 1   and 3) .

T A B L E 1 Baseline characteristics, risk factors, and vital signs in participants. that showed a high mortality rate of COVID-19-alone-of 37.5%. 39 And regarding comparison with other co-infection studies, the overall mortality among our coinfected participants was 40.4% (n = 63), in contrast to a cohort study done in Uganda that showed a mortality rate among COVID-19 and malaria coinfected patients of only 3%. 40 We believe that coinfection has a vital role prompting a high mortality rate due to the increased inflammatory response; also, we assume the mortality rate in our study to be inflated due to other factors; such as the lack of fundamental resources (lifesaving resources and adequate staff). P. falciparum overall mortality is difficult to obtain due to scarcity of data; but as stated in a study, P.

falciparum mono infection overall mortality in Sudan, was approximately 0.13% in 2019. 4 

WBCs counts, × 10 3 /L 155 Mean ± SD 11.5 ± 8.5 11.7 ± 9.6 11.3 ± 7.8 0.7

Median (interquartile range) 9.7 (6.8-13.4) 9.9 (6.9-13.0) 9.6 (6.7-13.6) 0.8

Hemoglobin, g/dL 153

Mean ± SD 11.9 ± 2.0 11.6 ± 2. b Wilcoxon rank-sum test; two sample t test.

T A B L E 4 Urine analysis, Chest X-ray, CT, and ECG findings. followed by heavy sweats, a high fever, and fatigue. 48 There is a scarcity in data regarding COVID-19 and malaria coinfection, but a study reported that most of the patients with coinfection had a fever as a presenting complaint, while some patients had headaches, difficulty breathing, and sore throats on presentation. 49 Regarding symptoms among our coinfected patients, we found shortness of breath (76.3%) and fever (73.1%) to be the most prevalent symptoms.

Our findings align with a study done in Uganda, where fever (21%, n = 70) and shortness of breath (19%, n = 70) were the second and fourth most common symptoms among COVID-19 and malaria coinfected patients, respectively. 40 Although both symptoms are considered among the most to occur, there is a substantial difference between the prevalence of occurrence among the two studies. This might be due to the treatment-seeking behavior of our patients, as many individuals wait until symptoms arise before seeking treatment. generation and findings like fever. 48 Malaria complications are diverse;

the most common include: Cerebral malaria, acute renal failure, pulmonary edema, severe anemia, and bleeding. 54 We found thrombocytopenia to be present in 16% (n = 156) of our patients. This is in contrast to a study, where Thrombocytopenia complicated 41.7%

(n = 12) of COVID-19 and malaria coinfections. 55 This may be attributed to the difference in sample size and further studies are needed to clarify the ambiguity.

In our patients, the overall concentration of total white blood cells was decreased, and C-reactive protein levels were increased. During malaria, white blood cell (WBC) counts are low or normal, a characteristic that is commonly regarded to represent leukocyte localization away from the peripheral circulation to the spleen and other marginal pools, instead of real deficiency or stasis. 56 In African studies, serum CRP levels have been linked to parasite burden and consequences in malaria, particularly falciparum malaria. 57 patients hence death. 51 We found acute respiratory distress syndrome to be significantly associated with in-hospital mortality; 63.5% (n = 55) of our patients with acute respiratory distress syndrome died. This is similar to a study where mortality was 52.4% (n = 84) among patients with acute respiratory distress syndrome. 51 The increased mortality rate is probably due to the increased inflammatory response due to the coinfection. Also, we found a length of stay of 5.4 ± 4.3 days to be significantly associated with in-hospital death (p = 0.003); and this is similar to a systematic review where-in terms of overall stay-those who died had a shorter stay than those who were discharged alive. 63 There is a possibility of a higher rate of COVID 

Almost two in five of our participants died with acute respiratory distress syndrome being the most common complication significantly associated with mortality; such a high rate is regarded as a public health concern, and more attention needs to be focused on 

The authors declare no conflicts of interest.

The data that support the findings of this paper is available with the corresponding author upon reasonable request.

All authors gave their verbal and written consent for publication.

Ethical approval was obtained from the Ministry of Higher Education, University of Gezira, Gezira State, Sudan. The ethical approval of each center's ethical committee was acquired. Both written and verbal consents were obtained from the participants or their guardians.

Privacy and protection of the participant's files and information were of the highest priority.

Khabab Abbasher Hussien Mohamed Ahmed https://orcid.org/

When is "malaria" malaria? The different burdens of malaria infection, malaria disease, and malaria-like illnesses

The global distribution of clinical episodes of Plasmodium falciparum malaria

Davidson's. Davidson's principles and practice of medicine

Letter: Acid secretion by gastric mucous membrane

Possible central role of nitric oxide in conditions clinically similar to cerebral malaria

Letters to the Editor immunochromatographic diagnosis malaria with hypoglycaemia

Update on malaria diagnostics and test utilization

The COVID-19 epidemic

WHO Director-General's opening remarks at the media briefing on COVID-19

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: estimation and application

A systematic literature review on COVID-19, clinical manifestation, laboratory and radiologic features

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis

Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis

Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management

Predictors of COVID-19 severity: a literature review

has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company' s public news and information

Malaria and COVID-19: common and different finding

Co-infection of COVID-19 and recurrent malaria

Co-infection with malaria and coronavirus disease -2019 Over 8000 Macaque Bites Since 2014 but No Herpes B Virus Infection Reported from Shimla, India

COVID-19 and Plasmodium vivax malaria co-infection. IDCases

Tailoring malaria interventions in the COVID-19 response

COVID-19 and malaria: a symptom screening challenge for malaria endemic countries

WHO Regional Office for Africa

World Health Organization. Management of severe malaria: a practical handbook

Global malaria eradication and the importance of Plasmodium falciparum epidemiology in Africa

The burden of malaria in Sudan: incidence, mortality and disability--adjusted life--years

How delayed and nonadherent treatment contribute to onward transmission of malaria: a modelling study

Asymptomatic" malaria: a chronic and debilitating infection that should be treated

A mathematical model for simulating the phase-based transmissibility of a novel coronavirus

Morbidity and mortality trends of Covid 19 in top 10 countries

Sudan: WHO. Coronavirus Disease (COVID-19) Dashboard With Vaccination Data

High mortality rate in adult COVID-19 inpatients in Eastern Sudan: a retrospective study

Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda

SARS-CoV-2/DENV co-infection: a series of cases from the Federal District, Midwestern Brazil

First report of epidemic dengue fever and malaria co-infections among internally displaced persons in humanitarian camps of North Darfur, Sudan

Risks and challenges of arboviral diseases in Sudan: the urgent need for actions

Detection of coinfection with Chikungunya virus and Dengue virus serotype 2 in serum samples of patients in State of Tocantins, Brazil

Prevalence of Malaria and Chikungunya co-infection in febrile patients: a systematic review and meta-analysis

Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus

Clinical characteristics of coronavirus disease 2019 in China

The role of sex in malaria-COVID19 coinfection and some associated factors in Rivers State

COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS

Characterisation of inhospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Clinical review: severe malaria

Prevalence and characteristics of malaria among COVID-19 individuals: A systematic review, meta-analysis, and analysis of case reports

White blood cell counts and malaria

Study of C reactive protein as a prognostic marker in malaria from Eastern India

C-reactive protein and clinical outcomes in patients with COVID-19

Elevated D-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: a systematic review and meta-analysis

Electrocardiographic manifestations of COVID-19

Predictors of outcome in childhood Plasmodium falciparum malaria

Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics

Altered mental status predicts length of stay but not death in a community-based cohort of hospitalized COVID-19 patients